Raymond Vanholder

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases

Hans Schepkens, Raymond Vanholder, Jean-Marie Billiouw et al. · The American Journal of Medicine · 2001 · 261 citations

Angiotensin-converting Enzyme Inhibitors, Hypertension, Medicine +6

EBPG guideline on dialysis strategies

James Tattersall, Alejandro Martín‐Malo, Luciano A. Pedrini et al. · Nephrology Dialysis Transplantation · 2007 · 258 citations · Full text

Dialysis, Renal Pathology, Dialysis Therapy +21

Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins.

Sanjay R. Patel, Hui Ke, Raymond Vanholder et al. · Journal of Clinical Investigation · 1995 · 139 citations · Full text

Nephrology, Osteoporosis, Molecular Pharmacology +17

Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of European Renal Best Practice (ERBP)

Raymond Vanholder, Bernard Canaud, Richard Fluck et al. · Clinical Kidney Journal · 2010 · 122 citations · Full text

Dialysis, Nephrology Section, Dialysis Therapy +21

A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Blood Pressure in Non-dialysis-dependent Chronic Kidney Disease: an endorsement with some caveats for real-life application

Francis Verbeke, E. Lindley, Lucas Van Bortel et al. · Nephrology Dialysis Transplantation · 2013 · 85 citations · Full text

Hypertension, Dialysis Therapy, Kidney Disease +24